Literature DB >> 376728

Production and characterization of DR xenoantisera: use for detection of serum DR antigens.

B S Wilson, F Indiveri, M A Pellegrino, S Ferrone.   

Abstract

Immunoadsorbents consisting of rabbit anti-DR antibodies bound to Staphylococcus aureus were used to bind DR antigens from NP40 cellular extracts of cultured B lymphoid cells. When injected into rabbits, these DR antibody absorbents elicited the production of antibodies that were shown by both serologic and immunochemical techniques to react specifically with the DR antigen molecule. A rosette inhibition assay with B lymphoid cells and anti-DR xenoantisera was used to detect DR antigens in human serum. DR serum antigens could be found in an enriched preparation of serum lipoproteins obtained by centrifugation in KBr. In addition, sera from some patients with neoplastic diseases contained higher levels of DR serum antigens than those found in normal individuals.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 376728

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: a paradigm in pregnancy.

Authors:  Irene Athanassakis; S Vassiliadis
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

2.  Cross-reactivity between human and murine lymphocyte antigens. IV. Reactivity of H-2 alloantisera with HLA-A, B antigens.

Authors:  V Quaranta; M A Pellegrino; G N Callahan; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

3.  The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells.

Authors:  C Russo; A K Ng; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

4.  Effect of polyclonal and monoclonal HLA-DR xenoantibodies on xenogeneic mixed lymphocyte reactions.

Authors:  C Russo; V Quaranta; F Indiveri; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

5.  Changes in Ia-like antigen expression on malignant human cells.

Authors:  P G Natali; C De Martino; V Quaranta; A Bigotti; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

6.  Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera.

Authors:  B S Wilson; N E Kay; K Imai; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

7.  The free and the beta 2-microglobulin-associated heavy chains of HLA-A, B alloantigens share the antigenic determinant recognized by the monoclonal antibody Q1/28.

Authors:  V Quaranta; L E Walker; G Ruberto; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

8.  Varying expression of major histocompatibility complex antigens on human renal endothelium and epithelium.

Authors:  P R Evans; L P Trickett; J L Smith; A G MacIver; D Tate; M Slapak
Journal:  Br J Exp Pathol       Date:  1985-02

9.  The monoclonal xenoantibody Q6/64 recognizes a determinant expressed by certain gene products of the A and B loci of the HLA region.

Authors:  V Quaranta; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

10.  Stimulation of human T lymphocytes by PHA-activated autologous T lymphocytes: analysis of the role of Ia-like antigens with monoclonal antibodies.

Authors:  C Russo; F Indiveri; V Quaranta; G A Molinaro; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.